Search Videos and More
News
Expand Treatment Options for Patients with Peritoneal Metastases
With an Early Cytoreduction Surgical Evaluation
News
The Storied Career Of Clinical Physicist Dr. Charlie Ma: From Philadelphia To Cancer Centers Worldwide
Over more than two decades at Fox Chase Cancer Center, Chang Ming Charlie Ma, PhD, FAAPM, FASTRO, Professor, Director of Physics, and Vice Chair of Radiation Oncology, helped transform clinical physics from a behind-the-scenes discipline into a force that reshaped how radiation therapy is planned, calculated, and delivered.
News
A Randomized Phase II/III Trial of Intraperitoneal Paclitaxel Plus Systemic Treatment vs Systemic Treatment Alone in Gastric Carcinomatosis – STOPGAP II (EA2234)
Can we lower the chance of gastric cancer from growing or spreading by administering paclitaxel chemotherapy directly into the abdominal cavity in addition to chemotherapy given through a vein in the arm? Will administering paclitaxel chemotherapy directly into the abdominal cavity, in addition to chemotherapy given through a vein in the arm help patients live longer?
News
Prehabilitation in High-Risk Oncologic Surgery: A Prospective Cohort Study (PRS III)
The goal of this clinical study is to learn whether a prehabilitation program can improve recovery after major abdominal surgery in adults with cancer who are receiving treatment before surgery.
News
Fox Chase Cancer Center at ASTRO 2026
We are pleased to highlight several Fox Chase–Temple sessions taking place at ASTRO 2026. Explore the sessions below as our faculty and residents share their work throughout the meeting — and be sure to visit us at Booth #1336 in the ASTRO Exhibit Hall.
News
Adaptive Radiation Boost for Rectal Cancer (ARBOR)
The goal of this clinical trial is to find out if giving extra adaptive radiation therapy after standard chemoradiation treatment is safe and helpful for people with rectal cancer.
News
Adaptive Radiation for Locally Advanced Unresectable Pancreatic Cancer
The goal of this clinical trial is to learn if Adaptive Radiation Therapy (ART) is safe and effective in treating patients with locally advanced pancreatic cancer.
News
Redefining Treatment Timelines for Platinum-Resistant Ovarian Cancer
“Integrating clinical trials and newer therapies earlier in a patient’s ovarian cancer treatment journey can make a significant difference in their outcome,” said Angela Jain, MD, Associate Professor, Department of Hematology/Oncology; Chief, Division of Gynecologic Medical Oncology; and Clinical Director of GYN/Well Women’s Health Clinical Service Line.
News
Expanding the Role and Responsibilities of Urologic Advanced Practice Providers
Since 2024, the Fox Chase – Temple Urologic Institute has grown exponentially, increasing demand for highly trained advanced practice providers (APPs) to work alongside attending specialists. Recently, eight new APPs have joined the team to address the expanding clinical needs in both urologic oncology and general urology, with clinic appointments often exceeding capacity.
News
Two New Carol and Louis Della Penna Chairs at Fox Chase
Carol and Louis Della Penna are two of Fox Chase Cancer Center’s most generous and committed supporters. Recently, two esteemed urologists received the honor of an endowed chair:
News
Preserving Life and Quality of Life in Muscle-Invasive Bladder Cancer
Fox Chase-developed RETAIN clinical trials explore bladder preservation for selected patients
News
U.S. News & World Report Recognizes Fox Chase Cancer Center Among Nation’s Best Hospitals for Cancer Care
U.S. News & World Report has ranked Fox Chase Cancer Center among the nation’s top hospitals for cancer care according to the publication’s 2026-27 Best Hospitals rankings.